DARAPRIM Side Effects

6724055-4 | Calculus Urinary, Tubulointerstitial Nephritis
on May 10, 2010 Female patient from SPAIN , 22 years of age, was diagnosed with hiv infection (What is hiv infection?), cerebral toxoplasmosis and was treated with Daraprim (View Usage). Patient experienced the following unwanted or unexpected effects: calculus urinary, tubulointerstitial nephritis. Daraprim dosage: . During the same period patient was treated with REYATAZ (400mg Per Day) (View Reyataz Review and Reyataz Label ), TRUVADA (View Truvada Review and Truvada Label ), SULFADIAZINA (1g Four Times Per Day) (View Sulfadiazina Review and Sulfadiazina Label ), DEXAMETASONA (6mg Per Day) (View Dexametasona Review and Dexametasona Label ), HIDROSALURETIL (50mg Per Day) (View Hidrosaluretil Review and Hidrosaluretil Label ). Patient was hospitalized.

6405685-6 | Anaemia Megaloblastic, Haemolysis, Hepatotoxicity, Off Label Use
Patient was taking Daraprim (View Usage). Patient had the following side effects: anaemia megaloblastic, haemolysis, hepatotoxicity, off label use on Oct 12, 2009 from GERMANY Additional patient health information: Male patient , 52 years of age, was diagnosed with malaria prophylaxis and. Daraprim dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (1000mg Per Day) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6000101-0 | Optic Ischaemic Neuropathy, Papilloedema
Adverse event was reported on Dec 08, 2008 by a Male patient taking Daraprim (View Usage) (Dosage: 25mg Twice Per Day) was diagnosed with toxoplasmosis and. Location: GERMANY , 76 years of age, weighting 163.1 lb, After Daraprim was administered, patient had the following side effects: optic ischaemic neuropathy, papilloedema. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), ASPIRIN (100mg Per Day) (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PRAVASTATIN SODIUM (10mg Per Day) (View Pravastatin Sodium Review and Pravastatin Sodium Label ), BAZOTON UNO (View Bazoton Uno Review and Bazoton Uno Label ), FUROSEMID (40mg Twice Per Day) (View Furosemid Review and Furosemid Label ), HEPAR SL FORTE (View Hepar Sl Forte Review and Hepar Sl Forte Label ). Patient was hospitalized.

5932768-7 | Premature Baby
on Oct 23, 2008 Female patient from UNITED STATES , 40 years of age, was diagnosed with toxoplasmosis and was treated with Daraprim (View Usage). Patient experienced the following unwanted or unexpected effects: premature baby. Daraprim dosage: . During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), SULFADIAZINE (View Sulfadiazine Review and Sulfadiazine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).


5817312-7 | Agranulocytosis
on Jul 17, 2008 Female patient from SPAIN , 46 years of age, was diagnosed with cerebral toxoplasmosis, hiv infection (What is hiv infection?) and was treated with Daraprim (View Usage). Patient had the following side effects: agranulocytosis. Daraprim dosage: 50mg Per Day. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), TRUVADA (View Truvada Review and Truvada Label ), SULPHADIAZINE (1000mg Four Times Per Day) (View Sulphadiazine Review and Sulphadiazine Label ), DEXAMETHASONE (24mg Per Day) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

5718011-2 | Eosinophilic Fasciitis, Folate Deficiency, Pancytopenia, Pyrexia
Patient was taking Daraprim (View Usage). After Daraprim was administered, patient had the following side effects: eosinophilic fasciitis, folate deficiency, pancytopenia, pyrexia on Apr 18, 2008 from SWITZERLAND Additional patient health information: Male patient , 50 years of age, was diagnosed with toxoplasmosis, hiv infection (What is hiv infection?) and. Daraprim dosage: 50mg Per Day. During the same period patient was treated with ZIAGEN (300mg Twice Per Day) (View Ziagen Review and Ziagen Label ), VIREAD (300mg Per Day) (View Viread Review and Viread Label ), KALETRA (View Kaletra Review and Kaletra Label ), CLINDAMYCIN HCL (900mg Three Times Per Day) (View Clindamycin Hcl Review and Clindamycin Hcl Label ). Patient was hospitalized.

5632821-1 | Dizziness, Hypoaesthesia, Vomiting
Adverse event was reported on Aug 14, 2007 by a Female patient taking Daraprim (View Usage) (Dosage: 200mg See Dosage Text) was diagnosed with toxoplasmosis and. Location: UNITED STATES , 37 years of age, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypoaesthesia, vomiting. During the same period patient was treated with CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

5475833-3 | Agranulocytosis, Fatigue, Hemiplegia, Leukopenia, Vomiting
on Sep 28, 2007 Female patient from SWITZERLAND , 39 years of age, was treated with Daraprim (View Usage). Patient had the following side effects: agranulocytosis, fatigue, hemiplegia, leukopenia, vomiting. Daraprim dosage: 25mg Three Times Per Day. During the same period patient was treated with SULFADIAZINE (500mg Four Times Per Day) (View Sulfadiazine Review and Sulfadiazine Label ), NEURONTIN (200mg Three Times Per Day) (View Neurontin Review and Neurontin Label ), FOLINIC ACID (15mg Per Day) (View Folinic Acid Review and Folinic Acid Label ).

5427545-X | Kidney Infection, Nephrolithiasis
on Aug 23, 2007 Female patient from UNITED STATES , 87 years of age, was treated with Daraprim (View Usage). After Daraprim was administered, patient had the following side effects: kidney infection, nephrolithiasis. Daraprim dosage: . During the same period patient was treated with DYAZIDE (View Dyazide Review and Dyazide Label ).

5392433-4 | Anaemia, Delivery, Leukopenia, Rash, Thrombocytopenia
Patient was taking Daraprim (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, delivery, leukopenia, rash (What is rash?), thrombocytopenia on Jul 16, 2007 from GERMANY Additional patient health information: Female patient , 30 years of age, was diagnosed with toxoplasmosis, prophylaxis and. Daraprim dosage: 25mg Per Day. During the same period patient was treated with SULFADIAZINE (500mg Four Times Per Day) (View Sulfadiazine Review and Sulfadiazine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

5308724-9 | Anaemia, Leukopenia, Rash, Thrombocytopenia
Adverse event was reported on Apr 23, 2007 by a Female patient taking Daraprim (View Usage) (Dosage: 25mg Per Day) was diagnosed with toxoplasmosis, prophylaxis and. Location: GERMANY , 30 years of age, Patient had the following side effects: anaemia, leukopenia, rash (What is rash?), thrombocytopenia. During the same period patient was treated with SULFADIAZINE (500mg Four Times Per Day) (View Sulfadiazine Review and Sulfadiazine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

5307244-5 | Kidney Infection, Nephrolithiasis
on Apr 23, 2007 Female patient from UNITED STATES , 87 years of age, was treated with Daraprim (View Usage). After Daraprim was administered, patient had the following side effects: kidney infection, nephrolithiasis. Daraprim dosage: . During the same period patient was treated with DYAZIDE (View Dyazide Review and Dyazide Label ).

5263819-3 | Kidney Infection, Nephrolithiasis
on Mar 12, 2007 Female patient from UNITED STATES , 87 years of age, was treated with Daraprim (View Usage). Patient experienced the following unwanted or unexpected effects: kidney infection, nephrolithiasis. Daraprim dosage: .

5223995-5 | Alopecia, Blood Disorder, Nervous System Disorder, Pruritus, Skin Hyperpigmentation, Tongue Ulceration
Patient was taking Daraprim (View Usage). Patient had the following side effects: alopecia, blood disorder, nervous system disorder, pruritus, skin hyperpigmentation, tongue ulceration on Jan 24, 2007 from GERMANY Additional patient health information: Female patient , 19 years of age, weighting 163.1 lb, was diagnosed with toxoplasmosis and. Daraprim dosage: 25mg Twice Per Day. During the same period patient was treated with SULFADIAZIN (500mg Per Day) (View Sulfadiazin Review and Sulfadiazin Label ).

5210702-5 | Alopecia, Blood Disorder, Nervous System Disorder, Skin Hyperpigmentation, Tongue Ulceration
Adverse event was reported on Jan 16, 2007 by a Female patient taking Daraprim (View Usage) (Dosage: ) was diagnosed with toxoplasmosis and. Location: GERMANY , 19 years of age, After Daraprim was administered, patient had the following side effects: alopecia, blood disorder, nervous system disorder, skin hyperpigmentation, tongue ulceration. During the same period patient was treated with SULFADIAZIN (View Sulfadiazin Review and Sulfadiazin Label ).

5120428-4 | Diarrhoea, Erythropenia, Headache, Leukopenia, Nausea, Thrombocytopenia
on Sep 01, 2006 Female patient from GERMANY , 18 years of age, was diagnosed with toxoplasmosis and was treated with Daraprim (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, erythropenia, headache (What is headache?), leukopenia, nausea (What is nausea?), thrombocytopenia. Daraprim dosage: 25mg Twice Per Day. During the same period patient was treated with SULFADIAZIN (500mg Four Times Per Day) (View Sulfadiazin Review and Sulfadiazin Label ).

5116679-5 | Supraventricular Tachycardia
on Jul 05, 2006 Male patient from GERMANY , weighting 8.60 lb, was diagnosed with congenital toxoplasmosis, neonatal infection and was treated with Daraprim (View Usage). Patient had the following side effects: supraventricular tachycardia. Daraprim dosage: 3mg Per Day. During the same period patient was treated with AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), SULFADIAZIN (150mg Twice Per Day) (View Sulfadiazin Review and Sulfadiazin Label ), LEDERFOLAT (View Lederfolat Review and Lederfolat Label ). Patient was hospitalized.

5046462-0 | Supraventricular Tachycardia
Patient was taking Daraprim (View Usage). After Daraprim was administered, patient had the following side effects: supraventricular tachycardia on Jul 05, 2006 from GERMANY Additional patient health information: Male patient , weighting 8.60 lb, was diagnosed with congenital toxoplasmosis and. Daraprim dosage: 3mg Per Day.

4742383-9 | Sarcoma
Adverse event was reported on Jul 26, 2005 by a Female patient taking Daraprim (View Usage) (Dosage: ) was diagnosed with toxoplasmosis and. Location: UNITED STATES , 56 years of age, Patient experienced the following unwanted or unexpected effects: sarcoma.

4712298-0 | Basophil Percentage Increased, Chorioretinitis, Chronic Myeloid Leukaemia, Eosinophil Percentage Decreased, Monocyte Percentage Decreased, Platelet Count Increased, Splenomegaly, Toxoplasmosis
on Jun 27, 2005 Female patient from UNITED STATES , 51 years of age, was diagnosed with toxoplasmosis and was treated with Daraprim (View Usage). Patient had the following side effects: basophil percentage increased, chorioretinitis, chronic myeloid leukaemia, eosinophil percentage decreased, monocyte percentage decreased, platelet count increased, splenomegaly, toxoplasmosis. Daraprim dosage: 50 Mg / Per Day /. During the same period patient was treated with SULPHAFURAZOLE (View Sulphafurazole Review and Sulphafurazole Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

4590860-6 | Nodule
on Oct 20, 2004 Female patient from , 53 years of age, was diagnosed with toxoplasmosis and was treated with Daraprim (View Usage). After Daraprim was administered, patient had the following side effects: nodule. Daraprim dosage: 75mg Per Day. During the same period patient was treated with SIMETHICON (View Simethicon Review and Simethicon Label ), REGLAN (View Reglan Review and Reglan Label ), VASOTEC (View Vasotec Review and Vasotec Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), ECOTRIN (View Ecotrin Review and Ecotrin Label ), COLACE (View Colace Review and Colace Label ), PREVACID (View Prevacid Review and Prevacid Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).